188 related articles for article (PubMed ID: 21163944)
1. Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma.
Jiang R; Shi Z; Johnson JJ; Liu Y; Stack MS
J Biol Chem; 2011 Mar; 286(11):9127-35. PubMed ID: 21163944
[TBL] [Abstract][Full Text] [Related]
2. Multiple kallikrein (KLK 5, 7, 8, and 10) expression in squamous cell carcinoma of the oral cavity.
Pettus JR; Johnson JJ; Shi Z; Davis JW; Koblinski J; Ghosh S; Liu Y; Ravosa MJ; Frazier S; Stack MS
Histol Histopathol; 2009 Feb; 24(2):197-207. PubMed ID: 19085836
[TBL] [Abstract][Full Text] [Related]
3. Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma.
Johnson JJ; Miller DL; Jiang R; Liu Y; Shi Z; Tarwater L; Williams R; Balsara R; Sauter ER; Stack MS
J Biol Chem; 2016 Mar; 291(13):6936-45. PubMed ID: 26839311
[TBL] [Abstract][Full Text] [Related]
4. Persistent kallikrein 5 activation induces atopic dermatitis-like skin architecture independent of PAR2 activity.
Zhu Y; Underwood J; Macmillan D; Shariff L; O'Shaughnessy R; Harper JI; Pickard C; Friedmann PS; Healy E; Di WL
J Allergy Clin Immunol; 2017 Nov; 140(5):1310-1322.e5. PubMed ID: 28238749
[TBL] [Abstract][Full Text] [Related]
5. hsa-miR-485-5p reverses epithelial to mesenchymal transition and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma.
Lin XJ; He CL; Sun T; Duan XJ; Sun Y; Xiong SJ
Int J Mol Med; 2017 Jul; 40(1):83-89. PubMed ID: 28535002
[TBL] [Abstract][Full Text] [Related]
6. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation.
Borgoño CA; Michael IP; Komatsu N; Jayakumar A; Kapadia R; Clayman GL; Sotiropoulou G; Diamandis EP
J Biol Chem; 2007 Feb; 282(6):3640-52. PubMed ID: 17158887
[TBL] [Abstract][Full Text] [Related]
7. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.
Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of kallikrein-related peptidase-4 in oral cancer.
Papagerakis P; Pannone G; Zheng LI; Athanassiou-Papaefthymiou M; Yamakoshi Y; McGuff HS; Shkeir O; Ghirtis K; Papagerakis S
Anticancer Res; 2015 Apr; 35(4):1861-6. PubMed ID: 25862839
[TBL] [Abstract][Full Text] [Related]
9. Desmoglein 1 Regulates Invadopodia by Suppressing EGFR/Erk Signaling in an Erbin-Dependent Manner.
Valenzuela-Iglesias A; Burks HE; Arnette CR; Yalamanchili A; Nekrasova O; Godsel LM; Green KJ
Mol Cancer Res; 2019 May; 17(5):1195-1206. PubMed ID: 30655320
[TBL] [Abstract][Full Text] [Related]
10. SPINK5 knockdown in organotypic human skin culture as a model system for Netherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7.
Wang S; Olt S; Schoefmann N; Stuetz A; Winiski A; Wolff-Winiski B
Exp Dermatol; 2014 Jul; 23(7):524-6. PubMed ID: 24848304
[TBL] [Abstract][Full Text] [Related]
11. Plakoglobin rescues adhesive defects induced by ectodomain truncation of the desmosomal cadherin desmoglein 1: implications for exfoliative toxin-mediated skin blistering.
Simpson CL; Kojima S; Cooper-Whitehair V; Getsios S; Green KJ
Am J Pathol; 2010 Dec; 177(6):2921-37. PubMed ID: 21075858
[TBL] [Abstract][Full Text] [Related]
12. The Co-Expression of Kallikrein 5 and Kallikrein 7 Associates with Poor Survival in Non-HPV Oral Squamous-Cell Carcinoma.
Leusink FK; van Diest PJ; Frank MH; Broekhuizen R; Braunius W; van Hooff SR; Willems SM; Koole R
Pathobiology; 2015; 82(2):58-67. PubMed ID: 26022646
[TBL] [Abstract][Full Text] [Related]
13. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
[TBL] [Abstract][Full Text] [Related]
14. Oral cancer overexpressed 1 (ORAOV1): a regulator for the cell growth and tumor angiogenesis in oral squamous cell carcinoma.
Jiang L; Zeng X; Yang H; Wang Z; Shen J; Bai J; Zhang Y; Gao F; Zhou M; Chen Q
Int J Cancer; 2008 Oct; 123(8):1779-86. PubMed ID: 18688849
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of Myosin 6 inhibits proliferation of oral squamous cell carcinoma cells.
Zhang X; Huang Z; Hu Y; Liu L
J Oral Pathol Med; 2016 Nov; 45(10):740-745. PubMed ID: 27561828
[TBL] [Abstract][Full Text] [Related]
16. Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer.
Ramani VC; Hennings L; Haun RS
BMC Cancer; 2008 Dec; 8():373. PubMed ID: 19091121
[TBL] [Abstract][Full Text] [Related]
17. The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis.
Fortugno P; Furio L; Teson M; Berretti M; El Hachem M; Zambruno G; Hovnanian A; D'Alessio M
Hum Mol Genet; 2012 Oct; 21(19):4187-200. PubMed ID: 22730493
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-378-3p/5p suppresses the migration and invasiveness of oral squamous carcinoma cells by inhibiting KLK4 expression.
Cui Z; Sun S; Liu Q; Zhou X; Gao S; Peng P; Li Q
Biochem Cell Biol; 2020 Apr; 98(2):154-163. PubMed ID: 31265790
[TBL] [Abstract][Full Text] [Related]
19. Differential roles of kallikrein-related peptidase 6 in malignant transformation and ΔNp63β-mediated epithelial-mesenchymal transition of oral squamous cell carcinoma.
Kaneko N; Kawano S; Yasuda K; Hashiguchi Y; Sakamoto T; Matsubara R; Goto Y; Jinno T; Maruse Y; Morioka M; Hattori T; Tanaka S; Tanaka H; Kiyoshima T; Nakamura S
Oral Oncol; 2017 Dec; 75():148-157. PubMed ID: 29224812
[TBL] [Abstract][Full Text] [Related]
20. Integrated proteomics identified up-regulated focal adhesion-mediated proteins in human squamous cell carcinoma in an orthotopic murine model.
Granato DC; Zanetti MR; Kawahara R; Yokoo S; Domingues RR; Aragão AZ; Agostini M; Carazzolle MF; Vidal RO; Flores IL; Korvala J; Cervigne NK; Silva AR; Coletta RD; Graner E; Sherman NE; Paes Leme AF
PLoS One; 2014; 9(5):e98208. PubMed ID: 24858105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
